Purchase Order 75D30122P14753
Award Date 9/15/22
Potential Completion Date 9/18/26
Potential Value $211K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of a NEXTSEQ 1000 SEQUENCING SYSTEM. The total potential value of the award is $205,800.00 with a completion date of August 23, 2021. Illumina has a history of providing sequencing equipment, consumables, and services to federal agencies such as the National...
- This firm fixed price BPA call was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $120,017.07 award is for Illumina's genomic sequencing solutions, including NextSeq, NovaSeq, MiSeq, and iSeq systems, to support the CDC's research and diagnostic needs. Illumina has previously provided sequencing platforms and services to other federal agencies...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the provision of a NEXTSEQ 1000 Sequencing system. The $205,800.00 contract has a completion date of September 30, 2022 and was awarded on August 2, 2022. Illumina has previously received prime federal contracts from agencies such as the National Institutes of Health, Department of...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $54,367.08 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the repair/replacement and advanced support plan for ISEQ equipment, with performance to be completed by August 20, 2028. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for preventative maintenance services on MISEQ and NOVASEQ sequencing instruments. The contract has a potential value of $125,869.80 and a completion date of November 19, 2022. Illumina has previously provided a range of sequencing systems, reagents, and services to support genomic research...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and software. The contract is for the purchase of a MiSeq System, a benchtop DNA sequencing platform, for $95,931. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received other federal prime and subcontract awards from agencies like the National Institutes of Health (NIH),...
- This firm fixed-price BPA call order was awarded by the Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $26,157.42 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, with a potential value of $159,999.10. The contract has a completion date of September 14, 2023 and was awarded on September 15, 2022. Illumina has previously received federal contract awards from agencies such as the NIH, USDA, and VA to provide a range of sequencing systems, reagents, and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of an ILLUMINA NS 1000 INSTRUMENT. The potential value of this award is $205,800.00. Illumina has previously received prime federal contract awards from various agencies like the NIH, CDC, USDA, and VA to provide a range of genomic sequencing systems, consumables, and...
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...